Literature DB >> 8411485

From the Food and Drug Administration.

S L Nightingale1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8411485     DOI: 10.1001/jama.270.14.1672

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Applying scientific criteria to therapeutic interchange: a balanced analysis of low-molecular-weight heparins.

Authors:  G J Merli; G J Vanscoy; T L Rihn; J B Groce; W McCormick
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

2.  Comparative glycomics using a tetraplex stable-isotope coded tag.

Authors:  Michael J Bowman; Joseph Zaia
Journal:  Anal Chem       Date:  2010-04-01       Impact factor: 6.986

3.  Guideline adherence for antithrombotic therapy in acute coronary syndrome: an overview in Dutch hospitals.

Authors:  W J Kikkert; J J Piek; R J de Winter; R J Peters; J P S Henriques
Journal:  Neth Heart J       Date:  2010-06       Impact factor: 2.380

4.  Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.

Authors:  Geno J Merli; James B Groce
Journal:  P T       Date:  2010-02

Review 5.  US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.

Authors:  Marc Cohen; Walter P Jeske; Jose C Nicolau; Gilles Montalescot; Jawed Fareed
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

Review 6.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

7.  Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.

Authors:  Jesús Honorato; Antonio Gómez-Outes; Antonio Navarro-Quilis; Javier Martínez-González; Eduardo Rocha; André Planès
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  Pharmacodynamic and pharmacokinetic properties of enoxaparin : implications for clinical practice.

Authors:  Jawed Fareed; Debra Hoppensteadt; Jeanine Walenga; Omer Iqbal; Qing Ma; Walter Jeske; Taqdees Sheikh
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Differentiation of parenteral anticoagulants in the prevention and treatment of venous thromboembolism.

Authors:  Jawed Fareed; Cafer Adiguzel; Indermohan Thethi
Journal:  Thromb J       Date:  2011-03-28

10.  Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.

Authors:  Paolo Prandoni
Journal:  Thromb J       Date:  2008-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.